Ischemic and hemorrhagic abdominal complications in COVID-19 patients: experience from the first Italian wave.
Ischemic and hemorrhagic abdominal complications in COVID-19 patients: experience from the first Italian wave.
复制标题
DOI：
10.1186/s40001-022-00793-x
复制
发表时间：
2022-08-31
影响因子：
4.2
通讯作者：
Sironi, Sandro
中科院分区：
文献类型：
--
作者：
Bonaffini, Pietro Andrea;Franco, Paolo Niccolo;Bonanomi, Alice;Giaccherini, Cinzia;Valle, Clarissa;Marra, Paolo;Norsa, Lorenzo;Marchetti, Marina;Falanga, Anna;Sironi, Sandro
To report ischemic and haemorrhagic abdominal complications in a series of COVID-19 patients. To correlate these complications with lung involvement, laboratory tests, comorbidities, and anticoagulant treatment. We retrospectively included 30 COVID-19 patients who undergone abdomen CECT for abdominal pain, between March 16 and May 19, 2020. Ischemic and haemorrhagic complications were compared with lung involvement (early, progressive, peak or absorption stage), blood coagulation values, anticoagulant therapy, comorbidities, and presence of pulmonary embolism (PE). Ischemic complications were documented in 10 patients (7 receiving anticoagulant therapy, 70%): 6/10 small bowel ischemia (1 concomitant obstruction, 1 perforation) and 4/10 ischemic colitis. Main mesenteric vessels were patent except for 1 superior mesenteric vein thrombosis. Two ischemia cases also presented splenic infarctions. Bleeding complications were found in 20 patients (all receiving anticoagulant treatments), half with active bleeding: hematomas in soft tissues (15) and retroperitoneum (2) and gastro-intestinal bleeding (3). Platelet and lymphocyte were within the normal range. d-Dimer was significantly higher in ischemic cases (p < 0.001). Most of the patients had severe lung disease (45% peak, 29% absorption), two patients PE. Ischemic and haemorrhagic abdominal complications may occur in COVID-19 patients, particularly associated to extended lung disease. CT plays a key role in the diagnosis of these potentially life- threatening conditions.
登录
查看更多内容
影响因子：
6.8
作者：
Zhang J;Garrett S;Sun J
通讯作者：
Sun J
影响因子：
19.7
作者：
Bhayana R;Som A;Li MD;Carey DE;Anderson MA;Blake MA;Catalano O;Gee MS;Hahn PF;Harisinghani M;Kilcoyne A;Lee SI;Mojtahed A;Pandharipande PV;Pierce TT;Rosman DA;Saini S;Samir AE;Simeone JF;Gervais DA;Velmahos G;Misdraji J;Kambadakone A
通讯作者：
Kambadakone A
影响因子：
4.3
作者：
Norsa L;Bonaffini PA;Caldato M;Bonifacio C;Sonzogni A;Indriolo A;Valle C;Furfaro F;Bonanomi A;Franco PN;Gori M;Smania V;Scaramella L;Forzenigo L;Vecchi M;Solbiati M;Costantino G;Danese S;D'Antiga L;Sironi S;Elli L
通讯作者：
Elli L
影响因子：
4
作者：
Perisetti, Abhilash;Gajendran, Mahesh;Goyal, Hemant
通讯作者：
Goyal, Hemant
DOI：
10.1038/s41569-020-00469-1
发表时间：
2021-03
期刊：
Nature reviews. Cardiology
影响因子：
--
作者：
Gu SX;Tyagi T;Jain K;Gu VW;Lee SH;Hwa JM;Kwan JM;Krause DS;Lee AI;Halene S;Martin KA;Chun HJ;Hwa J
通讯作者：
Hwa J